In vivo #CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation. From Lesly Calderón @lesly-calderon.bsky.social, Meinrad Busslinger and colleagues: rupress.org/jem/article/...
📘 Part of JEM #Immunology collection 👉 rupress.org/jem/collecti...
#AAI2026
Posts by Chris Sundling
IFNγ-induced memory in human #macrophages is sustained by the durability of #cytokine signaling itself. From Aleksandr Gorin, Alexander Hoffmann and colleagues @ucla.edu: rupress.org/jem/article/...
📘 Part of JEM #Immunology collection 👉 rupress.org/jem/collecti...
#AAI2026
Parse or 10x? any advice? we're thinking about trying Parse but would love some feedback from the #immunology community. this sequencing project is for lung #macrophages if that matters? please circulate and send me any info about your experiences!! @jeffmold.bsky.social have you used Parse?
So TB is back in a big way in the US — 10,388 cases last year, highest since 2011. Four straight years of increases after decades of decline. The mix is rough: reactivated latent infections, outbreaks in shelters and prisons, and federal funding getting slashed right when we need it most. 2025 numbers look even worse. We were supposed to be eliminating this disease, not watching it rebound. https://crowdbyte.ai/topics/deadly-infectious-disease-rebounds-in-us-after-eradication-hopes
#Tuberculosis ! "So TB is back in a big way in the US—10,388 cases last year.... The mix is rough: reactivated latent infections, outbreaks in shelters and prisons, and federal funding getting slashed right when we need it most."
crowdbyte.ai/topics/deadl...
www.threads.com/@crowd_byte/...
New #IJID editorial: Scientific advances in TB are accelerating, but global impact is not keeping pace. The challenge is no longer innovation—it is implementation.
🔗 Read more: https://ow.ly/3IJS50YzsyM
#WorldTBDay #EndTBwithISID #Tuberculosis #ISID
📣Still time to apply! Don’t miss your chance to secure an EFIS–EJI Travel Award! #EarlyCareerResearcher #Immunology
Two new KI studies published in @cp-immunity.bsky.social have mapped immune gene variation across multiple global populations and shown how these variations affect the ability to form neutralising antibodies, for example against the #influenza virus 🧪 #Immunology #Genetics news.ki.se/large-mappin...
#HIV overactivates the #immunesystem, causing long-term dysfunction. New research from Linköping University @liu.se shows the #lupus drug #anifrolumab may restore immune cell function, opening the door to immune repair strategies alongside antivirals. #Immunology www.linkedin.com/posts/drmelv...
Structural and genetic basis of #HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. From Roark, Habib, Shaw, Kwong, Shapiro et al.: rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
Yes! We Can End TB. Led by Africa. Powered by People.
This #WorldTBDay, we call on African governments to:
🔹 Strengthen people-centred TB services
🔹 Close the funding gap with domestic resources
🔹 Advance regional manufacturing
🔗 Read the letter from GFAN Africa: bit.ly/WTBD-GFANafr...
#EndTB
Deconvoluting the interplay of innate & adaptive immunity in BCG-induced nonspecific & #TB-specific host resistance. Perspective by @kerryhilligan.bsky.social et al rupress.org/jem/article/...
📘 Updates on the Immune Responses to #Tuberculosis & #HIV rupress.org/jem/collecti...
#KSTB26 #KSHIVVax26
The authors also created an online resource: the Karolinska Institutet Adaptive Immune Receptor Gene Variant Atlas (KIARVA) where you can download the updated dataset. Found here: kiarva.scilifelab.se
This is a massive effort by Martin Corcoran and Gunilla Karlsson Hedestam at @ki.se
If you work with B cells and clone antibodies or look at BCR sequences, this new study out in @cp-immunity.bsky.social is a must read: www.sciencedirect.com/science/arti...
More than 500 allelic variants identified in 25 different Global populations.
This matters for biology and SHM calculations!
"This World TB Day, as ever, the world has everything it needs to end tuberculosis in our lifetimes. Yet in 2024, 1·23 million people died of tuberculosis, indicating that tuberculosis persists as the world's deadliest infectious disease" @lancetgh.bsky.social
www.thelancet.com/journals/lan...
@yssi-immunology.bsky.social
I'll be speaking at the @yefis-immunology.bsky.social webinar next week. Tune in for some mRNA #tuberculosis vaccine updates.
This is wild and crazy-- IgG4 frequently switched Fab arms
#Immunosky
🧪
www.nature.com/articles/s41...
'After consecutive primary heterosubtypic infections, 4–6% of memory B cells in children are cross-group reactive. These imprinted B cells target the central stalk epitope of HA and exhibit major functional differences.'
#Immunology
www.nature.com/articles/s41...
The immune system in the #uterus can regenerate after uterus or bone marrow transplantation, finds a KI study published in Science Translational Medicine. The new insights may be significant for the treatment of infertility and pregnancy complications 🧪 #Immunology news.ki.se/the-uterus-i...
🔬 Help shape the future of immunology! The Journal of Immunology is seeking expert Section Editors to lead our peer-review process and maintain the highest standards of scientific excellence. Join the team today!
📅 Apply by March 31, 2026
🔗 https://ow.ly/oB1G50YoERS
#Immunology
Out now in #Science #Immunology! 👇
A new cell-free genomics framework from Rockefeller's Elizabeth Campbell in @cp-molcell.bsky.social isolates the primary impacts of transcription factors and establishes #tuberculosis as a model for understanding how genes are regulated.
🔗: https://bit.ly/4s8QScX
There are just a few days left to apply. #Tuberculosis 🧪🦠 #TBDrugDiscovery
🔬 Abstract submissions are OPEN for #Cytokines2026 in Glasgow! Deadline: May 15, 2026. Student/postdoc members can apply for travel awards at submission. Submit now: 2026.cytokinesociety.org/call-for-abs... #CytokineSociety #Immunology
Tomorrow, in #preprinthub2 @alisaiakupova.bsky.social will present a preprint from Xuyu Zhou’s lab on how #TCR signal strength determines #Treg instability and discrimination of self versus non-self antigens 🐁 ⏳🌪️ #immunosky
www.biorxiv.org/content/10.6...
Existing treatments for #tuberculosis and HIV control the pathogens, but the immune system does not revert to normal
The preclinical findings help explain why people living with #HIV likely remain more susceptible to other illness and reinfection with #TB – and point to the need for new therapies
LMU researchers led by Mikaela Coleman & Katharina Kranzer present an approach that views #tuberculosis as the result of broader systemic forces. The “tuberculogenic environment” sees TB not only as a medical problem, but as a consequence of broader systemic forces shaping health and vulnerability.🩺